当前位置: 首页 > 期刊 > 《医药产业资讯》 > 20208
编号:13496819
川芎嗪对血管内皮损伤的保护作用机制研究进展(5)
http://www.100md.com 2020年3月15日 《中国医药导报》 20208
     [29] Wu X,Zhang F,Xiong X,et al. Tetramethylpyrazine Reduces Inflammation in Liver Fibrosis and Inhibits Inflammatory Cytokine Expression in Hepatic Stellate Cells by Modulating NLRP3 Inflammasome Pathway [J]. IUBMB Life,2015,67(4):312-321.

    [30] Chen AF,Chen DD,Daiber A,et al. Free radical biology of the cardiovascular system [J]. Clin Sci(Lond),2012, 123(2):73-91.

    [31] Salisbury D,Bronas U. Reactive oxygen and nitrogen species:impact on endothelial dysfunction [J]. Nurs Res,2015,64(1):53-66.

    [32] Bedard K,Krause KH. The NOX family of ROS-generating NADPH oxidases:physiology and pathophysiology [J]. Physiol Rev,2007,87(1):245-313.

    [33] Ni Xj,Wong SL,Wong CM,et al. Tetramethylpyrazine Protects against Hydrogen Peroxide-Provoked Endothelial Dysfunction in Isolated Rat Aortic Rings:Implications for Antioxidant Therapy of Vascular Diseases [J]. Evid Based Complement Alternat Med,2014,2014(2):627181.

    (收稿日期:2019-09-04 本文編辑:封 华), 百拇医药(李芳芳 张琪)
上一页1 2 3 4 5